1032349-97-5

Basic information

• Product Name: tert-butyl 1-(4-cyanophenyl)cyclobutylcarbamate
• Synonyms: tert-butyl 1-(4-cyanophenyl)cyclobutylcarbamate;CarbaMic acid, N-[1-(4-cyanophenyl)cyclobutyl]-, 1,1-diMethylethyl ester;tert-butyl N-[1-(4-cyanophenyl)cyclobutyl]carbamate;cyclobutylcarbamate;tert-Butyl 1-(4-cyanophenyl);tert-Butyl 1-(4-cyanophenyl)cyclobutylcarbamate - C12112
• CAS NO: 1032349-97-5
• Molecular Formula: C₁₆H₂₀N₂O₂
• Molecular Weight: 272.3422
• Mol File: 1032349-97-5.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• Density: 1.13
• Storage Temp.: 2-8°C
• CAS DataBase Reference: tert-butyl 1-(4-cyanophenyl)cyclobutylcarbamate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 1-(4-cyanophenyl)cyclobutylcarbamate(1032349-97-5)
• EPA Substance Registry System: tert-butyl 1-(4-cyanophenyl)cyclobutylcarbamate(1032349-97-5)

Safety Data

• Hazardous Substances Data: 1032349-97-5(Hazardous Substances Data)

Usage

General Description

Tert-butyl 1-(4-cyanophenyl)cyclobutylcarbamate is a chemical compound with the molecular formula C16H22N2O2. It is a carbamate derivative that is commonly used as an intermediate in the synthesis of various pharmaceuticals, agrochemicals, and other organic compounds. It is a white crystalline solid that is soluble in organic solvents and has a low melting point, making it suitable for use in organic synthesis reactions. tert-butyl 1-(4-cyanophenyl)cyclobutylcarbamate is known for its ability to act as a source of cyclobutylcarbamate during chemical reactions, and it is often used as a building block for the design and development of new chemicals with diverse functional properties.

Upstream product

• 50921-39-6 1-(4-chlorophenyl)cyclobutane-1-carboxylic acid 
• 24424-99-5 di-tert-butyl dicarbonate 
• 557-21-1 zinc(II) cyanide 
• 1032349-96-4 tert-butyl [1-(4-chlorophenyl)cyclobutyl]carbamate 
• 557-21-1 dicyanozinc 

Downstream Products

• 1032349-98-6 tert-butyl 1-(4-(2-phenylacetyl)phenyl)cyclobutylcarbamate 
• 1032349-99-7 tert-butyl {1-[4-(5-chloro-3-phenyl-1,6-naphthyrindin-2-yl)phenyl]cyclobutyl}carbamate 
• 1199556-10-9 1-[4-(1-methyl-8-phenyl-[1,2,4]triazolo[4,3-a]-1,5-naphthyridin-7-yl)phenyl]cyclobutanamine 
• 1199556-09-6 7-[4-(1-aminocyclobutyl)phenyl]-8-phenyl-[1,2,4]triazolo[4,3-a]-1,5-naphthylidin-1-amine 
• 1199555-32-2 7-[4-(1-aminocyclobutyl)-8-phenyl]-[1,2,4]triazole[4,3-a]-1,5-naphthyridin-1-ol 
• 1199556-61-0 tert-butyl {1-[4-(6-chloro-3-phenyl-1,5-naphthyridin-2-yl)phenyl]cyclobutyl}carbamate 
• 1199556-21-2 7-[4-(1-aminocyclobutyl)phenyl]-N-ethyl-8-phenyl-[1,2,4]triazolo[4,3-a]-1,5-naphthyridin-1-amine 
• 1199556-62-1 tert-butyl {1-[4-(6-hydrazino-3-phenyl-1,5-naphthyridin-2-yl)phenyl]cyclobutyl}carbamate 
• 1199556-63-2 tert-butyl {1-[4-(1-hydroxy-8-phenyl-[1,2,4]triazole[4,3-a]-1,5-naphthyridin-7-y)phenyl]cyclobutyl}carbamate 
• 1199555-33-3 N-{1-[4-(1-hydroxy-8-phenyl-[1,2,4]triazolo[4,3-a]-1,5-naphthyridin-7-yl)phenyl]cyclobutyl}-2-(3-pyridinyl)acetamide 
• 1357270-60-0 1-(4-(4-phenylpyrrolo[1,2-a]pyrazin-3-yl)phenyl)cyclobutanamine hydrochloride 
• 1357159-08-0 tert-butyl 1-(4-(4-phenylpyrrolo[1,2-a]pyrazin-3-yl)phenyl)cyclobutylcarbamate 
• 1357159-07-9 tert-butyl 1-(4-(2-(2-formyl-1H-pyrrol-1-yl)-2-phenylacetyl)phenyl)cyclobutylcarbamate 
• 1355998-33-2 2-(4-(1-aminocyclobutyl)phenyl)-3-phenylimidazo[1,2-a]pyridine-7-carboxamide 

Relevant articles and documents

IL-23 ANTAGONISTS FOR TREATMENT OR PREVENTION OF SKIN RASH ASSOCIATED WITH TREATMENT WITH P13K/AKT PATHWAY INHIBITORS

The present invention provides methods for use of interleukin-23 (IL-23) antagonists to treat or prevent skin rash associated with treatment with PI3K/AKT pathway inhibitors, such as treatment of cancer.

INHIBITORS OF AKT ACTIVITY

The instant invention provides for compounds that inhibit Akt activity. In particular, the compounds disclosed selectively inhibit one or two of the Akt isoforms. The invention also provides for compositions comprising such inhibitory compounds and methods of inhibiting Akt activity by administering the compound to a patient in need of treatment of cancer.

Inhibitors of Akt activity

The instant invention provides for substituted naphthyridine compounds that inhibit Akt activity. In particular, the compounds disclosed selectively inhibit one or two of the Akt isoforms. The invention also provides for compositions comprising such inhibitory compounds and methods of inhibiting Akt activity by administering the compound to a patient in need of treatment of cancer.